Key post hoc analysis of the landmark Steno-2 trial showing that intensified, multifactorial treatment slows progression of diabetic nephropathy and renal function loss in microalbuminuric patients with T2DM
At Set Point Medical Weight Loss Clinic, we understand the complex relationship between weight and overall health
The Ozempic and weight loss drug litigation is currently in preliminary stages, with expectations of an increase in lawsuits as legal frameworks for filings are established
While peptide-based GLP-1 receptor agonists such as Exenatide, Liraglutide, Dulaglutide, and Semaglutide have demonstrated strong efficacy, there remains significant interest in developing next-generation therapies
Semaglutide offers a personalized approach to weight management, helping reduce cravings and support long-term lifestyle changes